• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Ocera Therapeutics, Inc. (OCRX)

    -NasdaqGM
    3.63 Up 0.11(3.13%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.52
    Open:3.47
    Bid:1.00 x 200
    Ask:3.70 x 200
    1y Target Est:12.33
    Beta:3.8396
    Earnings Date:Nov 11 - Nov 16 (Est.)
    Day's Range:3.47 - 3.70
    52wk Range:3.30 - 8.10
    Volume:35,764
    Avg Vol (3m):73,826
    Market Cap:72.18M
    P/E (ttm):N/A
    EPS (ttm):-1.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OCRX

    Comparison

    Symbol% ChgMkt Cap
    OCRXUp 3.13%72.18M
    THRX 0.00%1.62B
    IRWDUp 1.99%1.61B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):207.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.43
    Quarterly EPS Est (Sep-15) :-0.38
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hyperammonemia and hepatic encephalopathy in patient... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback